جستجوی استاد راهنمای دانشگاهی

Xiaojun Lianمشاهده پروفایل

دانشیار

• Stem Cell Biology
• Regenerative Medicine
• Gene Editing Techniques
• +۴ مورد دیگر

Xiaojun (Lance) Lian is an Associate Professor in the Department of Biology and Biomedical Engineering at Pennsylvania State University. He leads the Human Stem Cell Engineering Laboratory, focusing on regenerative medicine and stem cell-based therapies. His work integrates developmental principles, genome editing, and stem cell biology to address diseases like diabetes and cardiovascular disorders. Lian holds affiliations with the Huck Institutes of the Life Sciences and collaborates widely on projects spanning gene editing (e.g., MAGIK method), CAR-T cell engineering, and ultrasound imaging technologies. **Education**: Ph.D. in Chemical and Biological Engineering, University of Wisconsin-Madison (2012) Postdoctoral Training: Harvard University (Stem Cell & Regenerative Biology), Karolinska Institutet (Cell & Molecular Biology) **Research Interests**: Lian’s lab targets pluripotent stem cell differentiation into specialized cell types (e.g., pancreatic beta cells, cardiac cells). They develop novel tools like MAGIK for efficient gene editing and explore engineered cells for cancer immunotherapy. Key themes include: Stem cell-derived therapies for diabetes and heart disease Optogenetic control of cell fate decisions Acoustic reporter genes for non-invasive imaging **Awards**: 2017 BMES Junior Investigator Award 2016 CMBE Young Innovator Award Cozzarelli Prize (2012) for PNAS paper on Wnt signaling in cardiomyocyte differentiation **Grants & Lab**: NSF CAREER Award (2020) NIH Trailblazer Grant (2018) Lab members include Alessandro Howells (PhD), Hayley, and Jirong **Outreach**: Active presenter at conferences (BMES, ISSCR) and collaborator on industry partnerships for scalable stem cell manufacturing.

Barbara Slusherمشاهده پروفایل

استاد

• Neurobiology of Disease
• Drug Discovery
• Neuropharmacology
• +۴ مورد دیگر

Barbara Slusher, PhD, MAS, is a Professor of Neurology (primary), Psychiatry, Pharmacology, Neuroscience, Medicine, and Oncology at Johns Hopkins University School of Medicine. She serves as Director of Johns Hopkins Drug Discovery, Vice Director of the Pederson Brain Science Institute, and Co-Director of the JH Center for the Advancement of HIV Neurotherapeutics. Her research focuses on neurobiology of disease and translational drug discovery, with expertise in enzyme inhibition (e.g., GCPII, NSM2) for CNS disorders and cancer. Education: PhD and MAS degrees (details not explicitly listed) Research interests emphasize drug development for neurodegenerative diseases, HIV-associated neurocognitive disorders, and cancer metabolism. She leads a multidisciplinary team advancing 170+ publications and 75 patents. Current projects include prodrug design for glioblastoma and immuno-metabolism therapies. She co-founded Cerecor and Dracen Pharmaceuticals, and launched the International Consortium of Academic Drug Discovery (140+ institutions). Her lab personnel include 12+ researchers across roles like postdocs and assistant professors. Active collaborations involve academic-industry partnerships in CNS drug development and oncology.

• Tuberculosis
• Antimicrobial Resistance (AMR)
• Diagnostic Methods
• +۵ مورد دیگر

Francis Drobniewski is the Chair in Global Health and Tuberculosis at Imperial College London's Faculty of Medicine, Department of Infectious Disease. He holds honorary professorships at Queen Mary University of London, King's College London, and Bournemouth University. His roles include leadership in the NHS, WHO, and global health initiatives. He is a Fellow of the American Academy of Microbiology and ESCMID, and has served on multiple international committees addressing AMR and TB/HIV. Education: MA (Trinity College Dublin), MB BS (St Bartholomew's Medical College), PhD (University of Cambridge), MSc/DTM&H (London School of Hygiene & Tropical Medicine). Certifications include Good Clinical Practice (GCP) and leadership training. Research focuses on tuberculosis diagnostics, AMR mechanisms, and public health strategies for respiratory diseases. Key interests include TB/HIV co-infection dynamics, drug resistance evolution, and vaccine hesitancy mitigation. He leads projects funded by EU Horizon programs, NIHR, and Wellcome Trust. His work on the VAROT Study and EuCARE consortium addresses ototoxicity from aminoglycosides and SARS-CoV-2 variant impacts. He pioneered the UK National Mycobacterium Reference Laboratory and chairs WHO's European Lab Initiative. Awards: Fellowships in microbiology and ESCMID membership. Recognized for contributions to TB diagnostics and global health policy. Advising/Grants: Principal Investigator for EU-funded projects. Collaborates with industry on diagnostic development. Leads training programs in Eastern Europe and Ukraine. Directs Health Sciences Research Ltd, supporting early-career scientists. Labs: Former Director of UK's National TB Reference Lab (1996–2015). Currently advises NHS Dorset as a part-time Consultant Microbiologist. Research integrates clinical, social, and genetic data from longitudinal cohorts in Europe and LMICs.

• Clinical Sciences
• Medical Microbiology
• Pharmacology and Pharmaceutical Sciences
• +۳ مورد دیگر

Dr. Carolina Herrera is an Honorary Senior Research Fellow in the Department of Infectious Disease at Imperial College London's Faculty of Medicine . She holds affiliations with the Immuno-Pathology Network, Microbiome Network, and the Section of Immunology of Infection. Her research focuses on mucosal infection and inflammation, particularly using ex vivo tissue models to study HIV/SIV, HCV, and Zika virus transmission, as well as evaluating prevention strategies like pre-exposure prophylaxis (PrEP) and vaccines. Education : BSc in Chemistry and PhD in Biochemistry from the University of Barcelona, Spain. Postdoctoral training at Weill Medical College of Cornell University, USA, under Prof. John P. Moore. Research Interests : Mucosal immunity and viral transmission Preclinical evaluation of antiviral candidates Inflammation and microbial interactions in infectious diseases Her work has been funded by organizations including NIH, amfAR, EU Commission, and industry partners like Pfizer and Gilead. She has contributed to advancements in understanding HIV pathogenesis and developing innovative prevention tools through interdisciplinary collaborations.

• Vaccine Development
• Immunology
• RNA Technology
• +۷ مورد دیگر

Dr Paul McKay is an Advanced Research Fellow in the Department of Infectious Disease at Imperial College London's Faculty of Medicine. He leads research on self-amplifying RNA and mRNA vaccine technologies, focusing on immune response modulation and vaccine delivery systems. His work integrates virology, immunology, and biomedical engineering to address global health challenges like HIV, SARS-CoV-2, and zoonotic diseases. Education: B.Sc. (Hons) in Biochemistry, Imperial College London M.Sc. in Medical Immunology, Royal Postgraduate Medical School (now Imperial College) Ph.D. in Molecular Immunology, Imperial College London Research Interests: Design of novel vaccine delivery systems (lipid nanoparticles, polymers) Preclinical evaluation of mRNA and self-amplifying RNA vaccines Mucosal immunity mechanisms and antibody responses Therapeutic modulation of immune pathways Affiliations: Immuno-Pathology Network Section of Immunology of Infection Vaccine Research Network Grand Challenges in Global Health Initiative Future Vaccine Manufacturing Research (FVMR) Hub Scientific Contributions: Over 100 peer-reviewed publications 10 patents in vaccine technology Co-founder of an Imperial College biotech startup Advancing Vaccinology: Dr McKay's lab develops next-generation vaccines targeting emerging pathogens, optimizing delivery systems to enhance immune durability and cross-variant protection. Current projects include mRNA-based solutions for HIV, coronaviruses, and bacterial infections like Chlamydia.

Siyu Yuمشاهده پروفایل

استادیار

• Social Hierarchies
• Organizational Networks
• Status Acuity
• +۳ مورد دیگر

Siyu Yu is an Assistant Professor of Management & Organizations at the Ross School of Business, University of Michigan. Her research examines social hierarchies and networks in organizational contexts, focusing on how status perception, power dynamics, and network structures influence individual and team outcomes. Education: PhD in Management from New York University (2020). Courses Taught: Behavioral Theory in Management, Positively Leading People and Organizations. Research Interests: Status Acuity and Workplace Outcomes Advantageous Networks and Hidden Costs Power vs. Status Bases of Hierarchy Team Conflict and Dynamics Publications appear in journals like Organization Science , Journal of Applied Psychology , and Journal of Personality and Social Psychology .

Limin Maoمشاهده پروفایل

استاد

• Public Health
• Infectious Diseases
• Health Promotion
• +۷ مورد دیگر

Professor Limin Mao is a leading academic at the University of New South Wales (UNSW) , affiliated with the Faculty of Arts and Social Sciences . She serves as a core member of the Centre for Social Research in Health , where her work bridges public health, social research, and statistical analysis to address chronic infections and comorbidities. Education: PhD and MEdAdmin from UNSW; MBBS and MD from Fudan University, Shanghai Her research focuses on HIV, hepatitis, and sexually transmitted infections (STIs) prevention, with an emphasis on behavioral surveillance , mHealth , and health promotion among culturally and linguistically diverse (CALD) populations, including gay and bisexual men, people who inject drugs, and migrants. She has pioneered studies on treatment adherence, stigma, and social determinants of health. Recent publications highlight trends in PrEP adoption , digital health interventions , and co-design approaches to improve care for gender-diverse groups. Her work spans Australia and China, addressing disparities in hypertension and diabetes management through health information systems. Scientific Awards: Dean’s Award for Social Research Impact, UNSW (2014) ASHM Undergraduate/Junior Researcher Support in HIV/Hepatitis (2002) As an educator, she has taught public health policy to undergraduates and contributed to postgraduate programs in Australia and China. Her leadership in grants includes MRFF, NHMRC, and ARC-funded projects, reflecting her commitment to equitable healthcare solutions.

Charles Fosterمشاهده پروفایل

پژوهشگر

• Virology
• Genomics
• Bioinformatics
• +۴ مورد دیگر

Dr. Charles Foster is a Bioinformatics Researcher at the Virology Research Lab, UNSW/Prince of Wales Hospital. His work focuses on genomic analysis of viruses, particularly SARS-CoV-2, and developing bioinformatics tools for virology research. He holds a PhD in phylogenomics and has contributed to studies on viral evolution, transcriptomics, and pandemic response strategies. Education: Bachelor of Science (Advanced) with First Class Honours and University Medal from the University of Sydney. PhD research emphasized bioinformatics applications in evolutionary biology. Research interests include viral genomics, phylogenetic analysis, and the application of bioinformatics to infectious disease surveillance. His work bridges fundamental research and public health, with recent focus on SARS-CoV-2 genomic sequencing and viral evolution tracking. Key contributions include development of analytical pipelines for viral genomic data, and studies on HIV-1 sequencing methods, CMV neurodevelopmental effects, and RSV epidemiology. His publications highlight advancements in genomic methodologies and insights into viral adaptation mechanisms. Awards: Best PhD Thesis Award in his completion year. His research is supported by collaborations within the UNSW Health & Medicine faculty and Prince of Wales Hospital facilities.

Tamar Goldenbergمشاهده پروفایل

استادیار

• Public Health
• Sexual and Gender Minority Health
• Global Health
• +۶ مورد دیگر

Dr. Tamar Goldenberg is an Assistant Professor of Public Health Education at the University of North Carolina at Greensboro. Her work focuses on stigma reduction and health equity for sexual and gender minority communities, particularly transgender individuals. She employs mixed-methods approaches to examine intersections between policy, community resilience, and healthcare access in both U.S. and global contexts. Education: PhD in Health Behavior and Health Education, University of Michigan School of Public Health MPH in Global Health, Emory University BA in Psychology and Women’s Studies, University of Michigan Research interests emphasize transgender health, HIV prevention, intimate partner violence, and applying community-based participatory methods. Current projects include analyzing data from transgender women sex workers in the Dominican Republic and adapting PrEP promotion interventions for Spanish-speaking transgender populations. Her work consistently bridges structural stigma analysis with practical policy solutions. Dr. Goldenberg has collaborated with institutions like UNC Chapel Hill and George Washington University, focusing on global health equity. Her research highlights resilience mechanisms in marginalized communities and the impact of state policies on healthcare access. Despite no listed awards, her extensive publication record demonstrates impactful contributions to LGBTQ+ health literature. Research and advising focus on transgender youth health, with notable work on gender affirmation's role in mental health. She leads projects addressing healthcare disparities through community-driven interventions, reflecting her commitment to applied public health solutions.

Laurent Gueguenمشاهده پروفایل

استاد

• Molecular Evolution
• Phylogenetics
• Computational Biology
• +۴ مورد دیگر

Laurent Gueguen is a Professor at École Normale Supérieure de Lyon (ENS Lyon), specializing in molecular evolution, phylogenetics, and computational biology. He teaches mathematics, modeling in biology, and computer science in undergraduate and graduate programs (BEE@Lyon and Bioinfo@Lyon), focusing on programming in R and Python for biologists. His research emphasizes molecular modeling in evolution, particularly phylogeny, and involves developing the Bio++ suite of bioinformatics libraries with collaborators like Julien Dutheil. He also maintains the DGINN pipeline, co-developed with Léa Picard and Lucie ÉTIENNE, for detecting genetic innovations in gene families. His work spans evolutionary genomics, genomic tool development, and the integration of computational methods in biological research. Research Interests: Molecular evolution and phylogenetic analysis Computational methods in genomics and bioinformatics Evolutionary trajectories of viral and host proteins Genetic innovation detection and phylogenetic reconciliation Integration of sequence and genomic data for evolutionary studies Publications Highlight Trends: His recent work focuses on viral-host interactions (e.g., HIV-1, SARS-CoV-2), genome organization, and computational tools for phylogenetic analysis. Articles emphasize methodological advancements in evolutionary genomics, such as GC-biased gene conversion effects and ancestral genome reconstruction. Advising & Grants: Supervised PhD student Léa Picard. Collaborates with institutions like the Max Planck Institute for Evolutionary Biology and CIRI (ENS Lyon). His tools (Bio++, DGINN) are widely used in the field. Labs/Teams: Active in teams at ENS Lyon and collaborates with CIRI and international groups in bioinformatics and evolutionary biology.

Maik Jörg Lehmannمشاهده پروفایل

استاد

• Pathogen-Cell Interactions
• RNAi-Based Screening
• Microscopy Techniques
• +۴ مورد دیگر

Prof. Dr. Maik Jörg Lehmann is a Professor of Biochemistry, Cell Biology, and Microbiology at Technische Hochschule Bingen. He holds roles such as Deputy Chairman of the Examination Board for Biotechnology and Biological Safety Officer. His academic journey includes a PhD in Molecular Biology from Ruprecht-Karls-University Heidelberg (2002), postdoctoral research at Yale University School of Medicine, and leadership roles at institutes like the Humboldt University of Berlin and the German Cancer Research Center. He specializes in pathogen-cell interactions, RNAi-based screening, and advanced microscopy techniques. Research Focus: His work focuses on identifying host factors in viral infections through RNAi screens, visualizing pathogen dynamics using fluorescence and electron microscopy, and developing 3D cell culture models. Key projects involve collaborations with institutions like Yale University and the Wellcome Trust Center for Human Genetics. Awards: Recipient of the Klaus-Georg und Sigrid Hengstberger Prize (2007) for early-career scientists and the Teaching Excellence Award (2015) at Humboldt University. Grants & Labs: Leads research on HIV entry mechanisms, Plasmodium biology, and host-pathogen interactions. His lab employs cutting-edge imaging and bioinformatics tools to study cellular processes and viral replication.

Amanda Brownمشاهده پروفایل

دانشیار

• Neuroinflammation
• Neurovirology
• HIV-Associated Neurocognitive Disorders (HAND)
• +۷ مورد دیگر

Amanda Brown is an Associate Professor in the Department of Neurology at the Johns Hopkins University School of Medicine, where she leads a research laboratory focused on the neurobiology of disease. She is also the Director of the Johns Hopkins Internship in Brain Sciences Program, contributing significantly to neuroscience education and training. Research Interests: Her research centers on understanding how HIV-1 infection disrupts the blood-brain barrier and triggers chronic neuroinflammation, leading to neurocognitive disorders. A major focus is the role of the protein osteopontin (SPP1/OPN) as a central regulator in neuroinflammatory signaling pathways. Her lab uses primary cell cultures, humanized mouse models, human brain tissues, and advanced techniques such as sn-RNA-seq, multicolor immunofluorescence, and neuroimaging (PET/MRI) to study mechanisms of viral persistence and immune activation in the brain. Publication Trends: Over the past decade, Dr. Brown's publications have consistently explored the molecular and immunological mechanisms underlying HIV-associated neurocognitive disorders (HAND), with a growing emphasis on osteopontin as a key mediator. Her recent work investigates sex differences, synaptic dysfunction, fibrosis, and therapeutic strategies targeting OPN, reflecting a translational and systems-level approach to neuroinflammation. Scientific Awards: No specific awards were mentioned in the provided text. Advising and Grants: While specific students or grants are not listed, Dr. Brown leads a productive research lab and directs a formal internship program, indicating active mentorship. Her ongoing research, including manuscripts in revision and submission, suggests sustained extramural funding and collaborative science. Labs and Teams: The Brown Lab operates at the intersection of neurology, immunology, and virology, employing interdisciplinary methods and collaborations. The lab has developed specialized protocols for behavioral testing in immunodeficient humanized mice and integrates molecular, imaging, and computational tools (e.g., Imaris) to advance understanding of neuroinflammatory diseases.

Annie Luetkemeyerمشاهده پروفایل

استاد

• HIV therapeutic strategies
• COVID-19 treatment and prevention
• Sexually Transmitted Infections
• +۵ مورد دیگر

Annie Luetkemeyer, MD is a Professor in the School of Medicine at the University of California, San Francisco (UCSF), with affiliations at San Francisco General Hospital (SFGH). Her work focuses on HIV therapeutics, viral hepatitis treatment, sexually transmitted infections (STIs), and tuberculosis (TB) in the context of HIV coinfection. She has extensive experience in clinical trials, particularly regarding hepatitis C elimination strategies, post-exposure prophylaxis (DoxyPEP), and novel antiviral therapies. Education & Training: MD - Harvard Medical School (1999) AB in American Studies - Stanford University (1994) Infectious Diseases Fellowship - UCSF (2007) Advanced Training in Clinical Research - UCSF (2006) Internal Medicine Residency - UCSF (2003) Research Interests: Dr. Luetkemeyer's research addresses critical gaps in managing HIV and coinfections. Her work emphasizes: Optimizing antiretroviral therapy (ART) regimens Developing hepatitis C elimination strategies using direct-acting antivirals Post-exposure prophylaxis (PEP) for STIs like gonorrhea and syphilis Understanding immune reconstitution inflammatory syndrome (IRIS) in TB/HIV coinfection Evaluating digital health tools to improve treatment adherence Key Contributions: Her studies include: Leading the DoxyPEP trial evaluating doxycycline for STI prevention Pioneering community-based hepatitis C treatment models Meta-analyses of convalescent plasma for severe COVID-19 Investigating drug resistance patterns in Treponema pallidum Awards & Recognition: While no specific awards are listed, her extensive publication record and leadership in high-impact trials reflect significant contributions to infectious disease research. Labs & Collaborations: Based at UCSF/SFGH, she collaborates with global networks like the AIDS Clinical Trials Group (ACTG) and the Tuberculosis Trials Consortium (TBTC).

Timothy Beckerمشاهده پروفایل

پژوهشگر ارشد

• Stigma
• Global Mental Health
• Adolescent Health
• +۳ مورد دیگر

Timothy Becker, MD is a child and adolescent psychiatry fellow and post-doctoral research fellow at NewYork-Presbyterian Hospital, Columbia University Vagelos College of Physicians & Surgeons and the New York State Psychiatric Institute, Department of Psychiatry. As an Associate Scholar with the University of Pennsylvania's Center for Global Health, he conducts cross-cultural research on stigma in mental health and HIV/AIDS across Botswana, Chile, and the United States, with clinical collaborations extending to Liberia and Grenada. His educational trajectory includes: Medical degree from the University of Pennsylvania with research blocks in Botswana focusing on head trauma databases and mental illness stigma Psychiatry residency at the Icahn School of Medicine at Mount Sinai through the global mental health track Ongoing specialization in child and adolescent psychiatry at Columbia University Becker's research centers on culturally adapted stigma interventions using the "What Matters Most" framework, with particular emphasis on intersectional stigma among women living with HIV, adolescents with mental illness, and immigrant populations. His methodological approach integrates qualitative analysis with pragmatic clinical trials to develop context-specific measurement tools and behavioral interventions. Current projects address structural vulnerability in Botswana, culturally shaped gossip mechanisms in HIV stigma, and immigration impacts on Chinese communities in the US. Analysis of his publication portfolio reveals a cohesive research program spanning psychiatric rehabilitation, public health policy, and clinical HIV care, with consistent application of mixed-methods designs across low-resource settings. The work demonstrates increasing methodological sophistication from initial qualitative explorations to current intervention trials, while maintaining focus on culturally salient aspects of stigma resistance. Becker collaborates extensively with multi-national research teams across institutional boundaries, including partnerships with the New York State Psychiatric Institute, Columbia University, and international sites in Southern Africa and Latin America. His clinical work integrates global mental health perspectives into domestic US settings through community-based interventions for vulnerable populations.

• Global Mental Health
• HIV/AIDS
• Stigma Reduction
• +۷ مورد دیگر

Melissa Ann Stockton, PhD, MSPH, is an Assistant Professor in the Department of Psychiatry at the University of Pennsylvania and an Associate Scholar at the Center for Global Health. She is based in Lilongwe, Malawi, and conducts research across Malawi and South Africa, focusing on the integration of mental health and HIV care in low-resource settings. Her research interests center on mental health, HIV/AIDS, stigma reduction, and suicide prevention , particularly among adolescents and individuals living with HIV. She specializes in implementation science and the adaptation of evidence-based psychological interventions for global contexts. Her work emphasizes scalable, stigma-reducing models of care that improve access to mental health services. Dr. Stockton's recent publications reflect a strong focus on validating mental health screening tools in South Africa, understanding mental health among people with HIV on methadone in Vietnam, and scaling up evidence-based psychotherapies through technology and implementation science in multiple low- and middle-income countries. Her research consistently bridges epidemiology, clinical care, and public health policy. She has not listed any scientific awards in the provided text. Dr. Stockton leads major global health projects, including stigma-reduction interventions for depressed individuals living with HIV in Malawi and adapting suicide prevention strategies for youth with HIV. She likely mentors students and trainees through the University of Pennsylvania’s global health programs, though specific advisees are not named. Her work is supported by institutional and global health funding mechanisms, though specific grants are not detailed. She is actively involved in field-based research teams in Malawi and South Africa, working closely with local partners to implement and evaluate mental health programming. Her team focuses on integrating mental health into existing HIV care systems, developing feasible interventions, and training local providers.